Efficacy of remimazolam versus midazolam for procedural sedation: post hoc integrated analyses of three phase 3 clinical trials

Background and study aims Remimazolam is an ultra-short acting, fast onset/fast offset benzodiazepine for intravenous use in procedural sedation, general anesthesia, and Intensive Care Unit sedation. The aim of this work was to compare the efficacy of remimazolam versus midazolam dosed according to...

Full description

Bibliographic Details
Main Authors: Van-Anh Dao, Frank Schippers, Thomas Stöhr
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2022-04-01
Series:Endoscopy International Open
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/a-1743-1936

Similar Items